We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · October 24, 2020

XEN® Gel Stent vs PRESERFLO™ MicroShunt Implantation for Primary Open-Angle Glaucoma

Acta Ophthalmologica


Additional Info

Acta Ophthalmologica
XEN® Gel Stent Compared to PRESERFLO™ MicroShunt Implantation for Primary Open-Angle Glaucoma: Two-Year Results
Acta Ophthalmol 2020 Sep 10;[EPub Ahead of Print], LMJ Scheres, S Kujovic-Aleksov, WD Ramdas, RMPC de Crom, LCG Roelofs, TTJM Berendschot, CAB Webers, HJM Beckers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading